2019-04-10
美國食品藥物管理局于2019年4月9日核准通過治療骨質疏鬆的新藥[益穩挺]Evenity (學名: romosozumab)上市。這是一個全新種類的骨質疏鬆治療藥物，不但可以抑制骨質流失，還可以促進骨質生長 ，可望嘉惠許多骨質疏鬆的患者。 根據統計，每三位女性就有一位有可能發生骨質疏鬆性的骨折，隨著年紀漸長這個比例會越來越高。骨質疏鬆症的治療，過去以雙磷酸鹽類藥物爲主，近十年保骼麗上市後 […]
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.